Ali Khademhosseini

Cambridge, MA, United States of America

Ali Khademhosseini

This inventor holds 13 USPTO granted patents and 7 published patent applications and 1 EPO patent, primarily in Bioprinting Technology. Top assignees: The Brigham and Women's Hospital, Inc., Tufts University, Harvard College. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ali Khademhosseini. Retrieved from https://idiyas.com/inventor/ali-khademhosseini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 92.3

 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Cambridge, MA (US) (2017 - 2024)
  • Los Angeles, CA (US) (2022 - 2024)

Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Bioadhesive
Corneal Repair
Bioprinting
Elastic Biopolymer
Tissue Adhesive
Pulp Regeneration
Microfluidics
Stereolithographic Printing
Additive Manufacturing
Hydrogel
Polypeptide Compositions
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ali Khademhosseini

Introduction

Ali Khademhosseini is a notable inventor based in Cambridge, MA, who has made significant advancements in the field of biomedical engineering. With a remarkable portfolio of 12 patents, his work primarily focuses on bioprinting technologies and tissue adhesives that have the potential to revolutionize medical treatments.

Latest Patents

Among his recent developments, two notable patents stand out. The first is titled "Systems and methods for in vivo multi-material bioprinting." This invention describes innovative systems and methods designed to fabricate biomedical constructs within a patient using a minimally invasive approach. The system employs a multi-material bioprinter, which features a biocompatible portion, ensuring safe integration into the human body. This printhead includes several outlets, each connected to different reservoirs containing unique bioinks, which can be selectively activated for precise bioprinting.

The second patent, "Elastic biopolymer and use as a tissue adhesive," presents an enhanced tissue adhesive formulated to repair soft tissue defects effectively. Lab tests have demonstrated that the crosslinked methacryloyl-substituted gelatin hydrogel, known as GelSEAL, outperforms traditional adhesives, such as fibrin and poly(ethylene glycol) glues, in terms of wound closure strength and shear resistance. Chronic in vivo experiments showcased GelSEAL’s capability in sealing large lung leakages without the need for sutures or staples, while also exhibiting excellent biocompatibility and low inflammatory responses.

Career Highlights

Ali Khademhosseini has collaborated with prominent institutions, such as the Brigham and Women's Hospital and Tufts University, reinforcing his commitment to advancing medical science through research and innovation. His background and expertise in biomedical engineering have enabled him to contribute significantly to the development of new technologies that address real-world health issues.

Collaborations

Throughout his career, Khademhosseini has worked alongside distinguished colleagues, including Nasim Annabi and Yu Shrike Zhang. These collaborations highlight the teamwork approach prevalent in innovative research environments, fostering the exchange of ideas and expertise that drives progress in their field.

Conclusion

In summary, Ali Khademhosseini's innovative contributions to the fields of bioprinting and tissue adhesives mark him as a leading inventor in biomedical engineering. His patents, notably in vivo multi-material bioprinting and advanced tissue adhesives, showcase his dedication to improving medical treatments and patient outcomes, solidifying his legacy as an influential figure in contemporary innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…